Home > Financial Ratios > WINDLAS BIOTECH

WINDLAS BIOTECH
EV/Core EBITDA

    Back to All Ratios
COMMUNITY POLL
for WINDLAS BIOTECH
Please provide your vote to see the results

WINDLAS BIOTECH Last 5 Year EV/Core EBITDA History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
   EV/Core EBITDA(x) 12.9319.5611.296.365.92

What is the latest EV/Core EBITDA ratio of WINDLAS BIOTECH ?

The latest EV/Core EBITDA ratio of WINDLAS BIOTECH is 12.93 based on Mar2026 Consolidated results.
Year EV/Core EBITDA
Mar202612.93
Mar202519.56
Mar202411.29
Mar20236.36
Mar20225.92

How is EV/Core EBITDA of WINDLAS BIOTECH Trending?

Years EV/Core EBITDA % Change
Mar2026 12.93
-33.90
Mar2025 19.56
73.25
Mar2024 11.29
77.52
Mar2023 6.36
7.43
Mar2022 5.92 -

Other Financial Ratios of WINDLAS BIOTECH


Compare EV/Core EBITDA ratio of peers of WINDLAS BIOTECH

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
WINDLAS BIOTECH ₹1,796.6 Cr -5% -20.9% -2.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹418,204.0 Cr -1% -5.5% 5.7% Stock Analytics
DIVIS LABORATORIES ₹238,497.0 Cr -2.6% -3.9% 38.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹170,481.0 Cr -1.7% -10.2% 30.5% Stock Analytics
CIPLA ₹108,012.0 Cr 0.9% -3.2% -15.2% Stock Analytics
DR REDDYS LABORATORIES ₹102,207.0 Cr -0.6% 1% -0.1% Stock Analytics


WINDLAS BIOTECH Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
WINDLAS BIOTECH

-5%

-20.9%

-2.5%

SENSEX

-1.6%

-2.3%

-11.5%


You may also like the below Video Courses